What is Advanced Targeting Systems?
Operating at the intersection of biotechnology and precision research, Advanced Targeting Systems provides critical infrastructure for experimental cellular analysis. The company distinguishes itself through a specialized portfolio of custom conjugations and advanced targeting solutions designed to meet the rigorous demands of modern research institutions and pharmaceutical developers. By streamlining complex laboratory workflows, the firm has established itself as a vital partner for organizations seeking to accelerate their discovery pipelines. Their market position is defined by a commitment to technical excellence and the delivery of tailored services that address specific, high-stakes experimental requirements within the global life sciences sector.
How much funding has Advanced Targeting Systems raised?
Advanced Targeting Systems has raised a total of $119K across 1 funding round:
Debt
$119K
Debt (2021): $119K with participation from PPP
Key Investors in Advanced Targeting Systems
PPP
Public-Private Partnership
What's next for Advanced Targeting Systems?
With this late-stage capital, Advanced Targeting Systems is well-positioned to scale its operational capacity and expand its reach into new therapeutic research markets. The strategic deployment of these funds will likely focus on enhancing the firm's R&D infrastructure, allowing for the development of next-generation targeting systems that address emerging challenges in cellular diagnostics. As the company transitions into this growth phase, stakeholders will be monitoring its ability to leverage these resources to capture greater market share and solidify its reputation as a leader in custom biological solutions. The focus remains on long-term value creation through sustained innovation and the deepening of its client service ecosystem.
See full Advanced Targeting Systems company page
